\
&
Contact us
\
&
Contact us
Published on | 9 months ago
ProgrammesOn 10 November 2025, Switzerland and the EU signed an agreement enabling Swiss participation in Horizon Europe and Digital Europe and Euratom, and this retroactively to 1 January 2025. This means that researchers and innovators can participate as beneficiaries in Horizon Europe and Digital Europe from the 2025 programme year onwards and can submit project proposals in the role of coordinators.
Many details about participation of Switzerland in Horizon Europe and Digital Europe can be found in an extensive FAQ list of SERI, the Swiss administration.
Regarding participation in strategic areas:
Additionally, the agreement lays the groundwork for Switzerland’s future participation in other EU programmes like Erasmus+ (expected to begin in 2027) and EU4Health, which is contingent upon the health agreement's activation within the Switzerland-EU package.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
